Engineered CAR-monocytes coordinate fibrosis clearance and cardiac regeneration following myocardial infarction
Cell Stem Cell · 2026-06 · 33 (6) · 913-929.e7
DOI: 10.1016/j.stem.2026.04.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Stem Cell, 2026-06. Verfasst von Zhenguo Wu und 20 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research of Minist…. Hauptthemen laut MEDLINE: Myocardial Infarction, Regeneration, Monocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation, Key Technologies Research and Development Program, National Key Research and Development Program of China.
Abstract (Originalsprache)
Overwhelming cardiomyocyte death and excessive cardiac fibrosis post myocardial infarction (MI) collectively lead to heart failure and mortality. For treating this devastating disease, it is essential to eliminate fibrosis and reconstitute the damaged myocardium, yet effective strategies remain elusive. Here, we created pleiotropic chimeric antigen receptor-monocytes (pCAR-Mos), revitalizing the injured heart via synergistic fibrosis clearance and myocardial reconstitution. Specifically, we engineered monocytes to express fibroblast activation protein (FAP)-chimeric antigen receptor (CAR) and secrete the cardioregenerative protein Agrin. CAR-mediated phagocytosis of myofibroblasts, which was further enhanced by Agrin, significantly attenuated fibrotic scar formation. Moreover, Agrin secretion promoted cardiomyocyte regeneration, thereby facilitating replenishment of functional myocardium. Treatment with pCAR-Mos remodeled the cardiac fibrotic microenvironment and substantially restored cardiac function in MI mice. In sum, our findings confirmed that pCAR-Mos exerted potent phagocytic activity against profibrotic myofibroblasts while simultaneously enabling myocardial reconstitution, thereby providing a reversible treatment strategy for MI with broad application in other fibrotic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research of Ministry of Education-Singapore, National Humanities Center, Chinese Academy…
- Shandong Key Laboratory of Targeted Drug Delivery and Advanced Pharmaceutics, NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, NMPA Key Laboratory for Technology Research and Evaluation of Dr…
Förderung
- Shandong Province Natural Science Foundation
- Key Technologies Research and Development Program
- National Key Research and Development Program of China
- Key Technology Research and Development Program of Shandong
- National Natural Science Foundation of China
Zitieren
APA
Wu, Z., Zou, X., Chen, C., Zhou, M., Yue, X., Guo, D., Gao, Y., Ma, C., Han, Q., Yang, D., Zang, D., Song, R., Li, Y., Pang, S., Ren, H., Zhang, W., Zhang, M., Zhang, Y., Yang, J., …, & Zhang, C. (2026). Engineered CAR-monocytes coordinate fibrosis clearance and cardiac regeneration following myocardial infarction. Cell Stem Cell, 33(6), 913-929.e7. https://doi.org/10.1016/j.stem.2026.04.003
Vancouver
Wu Z, Zou X, Chen C, Zhou M, Yue X, Guo D, et al. Engineered CAR-monocytes coordinate fibrosis clearance and cardiac regeneration following myocardial infarction. Cell Stem Cell. 2026;33(6):913-929.e7. doi:10.1016/j.stem.2026.04.003
BibTeX
@article{Wu2026,
author = {Wu, Zhenguo and Zou, Xiaohan and Chen, Chen and Zhou, Mengge and Yue, Xiao and Guo, Dachuan and Gao, Yunqian and Ma, Chang and Han, Qingmei and Yang, Danning and Zang, Dejin and Song, Ruicheng and Li, Yifei and Pang, Shujie and Ren, Haoran and Zhang, Wencheng and Zhang, Meng and Zhang, Yun and Yang, Jianmin and Jiang, Xinyi and Zhang, Cheng},
title = {Engineered CAR-monocytes coordinate fibrosis clearance and cardiac regeneration following myocardial infarction},
journal = {Cell Stem Cell},
year = {2026},
volume = {33},
number = {6},
pages = {913--929.e7},
doi = {10.1016/j.stem.2026.04.003}
}
EUVIMED